David Semela

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Homie Razavi, Imam Waked, Christoph Sarrazin et al. · Journal of Viral Hepatitis · 2014 · 484 citations · Full text

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Jonel Trebicka, Javier Fernández, Mária Papp et al. · Journal of Hepatology · 2020 · 478 citations · Full text

Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease

Antonina Mikocka‐Walus, Valérie Pittet, Jean‐Benoît Rossel et al. · Clinical Gastroenterology and Hepatology · 2016 · 339 citations · Full text

Clinical Recurrence, Psychological Co-morbidities, Functional Gastrointestinal Disorder +11

Porto-sinusoidal vascular disease: proposal and description of a novel entity

Andrea De Gottardi, Pierre‐Emmanuel Rautou, Jeoffrey Schouten et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 282 citations

Novel Entity, Vascular Disease, Cardiovascular Disease +9